| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/25/2004 | EP1390468A2 Identification of essential genes of aspegillus fumigatus and methods of use |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390409A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390401A2 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof |
| 02/25/2004 | EP1390397A1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390389A2 Cripto blocking antibodies and uses thereof |
| 02/25/2004 | EP1390387A2 Cancer-testis antigens |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
| 02/25/2004 | EP1390074A1 Novel compositions and uses therefor |
| 02/25/2004 | EP1390070A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 02/25/2004 | EP1390068A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists |
| 02/25/2004 | EP1390067A1 Compositions for use in treating ige-associated disorders |
| 02/25/2004 | EP1390066A2 Vaccine composition |
| 02/25/2004 | EP1390065A2 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit |
| 02/25/2004 | EP1390064A2 Method of treating malignancies through induction of blood immune responses |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1389997A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 02/25/2004 | EP0866861B1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 02/25/2004 | EP0820515B1 Phospholipase c homolog |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/25/2004 | EP0665888B1 Ryegrass pollen allergen |
| 02/25/2004 | CN1478146A Calcium binding proteins |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1477973A Split enveloped virus preparation |
| 02/25/2004 | CN1477972A Method for botaining antigenic aggregates and use thereof in formulations |
| 02/25/2004 | CN1477971A Split enveloped virus preparation for intranasal delivery |
| 02/25/2004 | CN1477970A 疫苗 Vaccine |
| 02/25/2004 | CN1477202A Schistosomiasis japonica (Chinese Continental strain) MFS4 gene clone, expression amd DNA vacine |
| 02/25/2004 | CN1477192A Recombinant pseudo-rabies virus expressing swine parvovirus VP2 gene and vacine and its preparation method |
| 02/25/2004 | CN1477128A Preparation method of specific IgY for resisting respiratory tract infection and its compound preparation |
| 02/25/2004 | CN1477127A Anti-venerism specific compound vitelline antibody and its application for curing venerism |
| 02/25/2004 | CN1476895A Avermectin or ivermectin and sheep clostridial disease vacine mixed preparation |
| 02/25/2004 | CN1476894A SARS epidemic lung tissue cytoplasmic bacterium purified and refined series vacine and its production method |
| 02/24/2004 | US6696562 Avian astrovirus |
| 02/24/2004 | US6696424 Cytofectin dimers and methods of use thereof |
| 02/24/2004 | US6696291 Synthetic HIV gag genes |
| 02/24/2004 | US6696289 Vector having nongenomic sequences coding for multiple cloning site and 3c-protease cleavage site between first and second amino acids of long polyprotein of sabin 1 poliovirus cdna |
| 02/24/2004 | US6696281 Chimeric flavivirus vaccines |
| 02/24/2004 | US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein |
| 02/24/2004 | US6696263 PCNA associated cell cycle proteins, compositions and methods of use |
| 02/24/2004 | US6696247 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/24/2004 | US6696242 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 02/24/2004 | US6696089 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 02/24/2004 | US6696065 Acellular pertussis vaccines and methods of preparation thereof |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6696061 Binds human major histocompatibility complex (mhc) class ii allotype |
| 02/24/2004 | US6696060 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 02/24/2004 | CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/24/2004 | CA2102036C Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus |
| 02/19/2004 | WO2004015390A2 Lung cancer target proteins and use thereof |
| 02/19/2004 | WO2004015118A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015099A2 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 02/19/2004 | WO2004015098A2 Rhesus epithelial cell adhesion molecule, nucleic acid encoding the same, and uses thereof |
| 02/19/2004 | WO2004015073A2 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015072A2 Mrbs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | WO2004015071A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004015070A2 Isolation and identification of t cells |
| 02/19/2004 | WO2004015056A2 Immunomodulating compositions, processes for their production and uses therefor |
| 02/19/2004 | WO2004014957A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 02/19/2004 | WO2004014956A1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 02/19/2004 | WO2004014954A1 Exosome containing exogenous antigen through gene transfection and method for utilizing the same |
| 02/19/2004 | WO2004014953A2 Anti-myelin associated glycoprotein (mag) antibodies |
| 02/19/2004 | WO2004014945A1 Gp41 epitope and uses thereof for the treatment of hiv infections |
| 02/19/2004 | WO2004014936A2 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 02/19/2004 | WO2004014905A1 Substituted benzimidazole compounds |
| 02/19/2004 | WO2004014899A1 Thiophene compounds |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014421A1 Use of antibodies against a tumor-associated antigen |
| 02/19/2004 | WO2004014420A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | WO2004014419A1 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| 02/19/2004 | WO2004014418A2 Neisserial vaccine compositions comprising a combination of antigens |
| 02/19/2004 | WO2004014417A2 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 02/19/2004 | WO2004014387A1 COMBINATION THERAPY WITH p38 MAP KINASE INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS |
| 02/19/2004 | WO2004014367A2 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease |
| 02/19/2004 | WO2004014322A2 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 02/19/2004 | WO2004014314A2 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | WO2004014311A2 Nogo receptor antagonists |
| 02/19/2004 | WO2004014301A2 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 02/19/2004 | WO2004014295A2 Tiacumicin production |
| 02/19/2004 | WO2004007726A3 Brachyspira hyodysenteriae vaccine |
| 02/19/2004 | WO2004007539A3 Hsp70 from arthrobacter |
| 02/19/2004 | WO2004006953A3 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 02/19/2004 | WO2003103706A3 Immunogenic compositions comprising a xenogenic prostate protein p501s |
| 02/19/2004 | WO2003100060A3 Muc-1 antigen with reduced number of vntr repeat units |
| 02/19/2004 | WO2003099193A3 Vaccines |
| 02/19/2004 | WO2003097852A3 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/19/2004 | WO2003088994A3 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/19/2004 | WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003079968A3 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ |
| 02/19/2004 | WO2003078658A3 Methods for diagnosing and treating schizophrenia |
| 02/19/2004 | WO2003065046A3 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| 02/19/2004 | WO2003065010A3 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis |
| 02/19/2004 | WO2003059251A3 Antibody targeting compounds |
| 02/19/2004 | WO2003052051A3 Adeno-associated virus (aav) serotype 8 sequences |
| 02/19/2004 | WO2003051913A3 Antigens for actinobacillus pleuropneumoniae and methods thereof |